drugset / Trial / NCT02813551

ToRsemide for pOstpartum HYpertension

NCT02813551

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Currently there is no intervention to prevent persistent postpartum hypertension in preeclamptic women. Physiologically, the use of a pharmacokinetically predictable loop-diuretic is a reasonable intervention to increase elimination of extra fluid accumulated secondary to preeclampsia.The purpose of this study is to assess if Torsemide reduces the incidence of persistent postpartum hypertension in preeclamptic women.

Timeline

Start
2016-08
Primary completion
2017-07-28
Completion
2017-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Torsemide Other / unclassified 20 mg Oral

Indications